A critical advance in cancer study is arising with the use of VHH fragments to reactivate mutated p53. This essential malignant inhibitor protein is frequently lost in many kinds of tumors, leading uncontrolled tissue https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research